These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 9530765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M, Rouillon F, Nuss P, Bazin N, Farah S, Djaballah K, Gerard D.
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [Abstract] [Full Text] [Related]

  • 5. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA, Burns T, Kemmler G, Fleischhacker WW.
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [Abstract] [Full Text] [Related]

  • 6. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z, Britvić D, Vuković O, Ille T.
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [Abstract] [Full Text] [Related]

  • 7. What is the schizophrenic patients' level of information about their disease and their treatment?
    Ferreri M, Rouillon F, Nuss P, Bazin N, Farah S, Djaballah K, Gerard D.
    Encephale; 2000 Oct; 26 Spec No 1():15-22. PubMed ID: 11294058
    [Abstract] [Full Text] [Related]

  • 8. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP, Buchkremer G, Redbrake M, Klingberg S.
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC.
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [Abstract] [Full Text] [Related]

  • 13. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC, Liu YP.
    Compr Psychiatry; 2010 Sep; 51(6):557-65. PubMed ID: 20965300
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M, Scheel T, Eich FX.
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ["Knowing--enjoying--better living". A seminar for persons with psychosis to improve their quality of life and reduce their vulnerability].
    Sibitz I, Gössler R, Katschnig H, Amering M.
    Psychiatr Prax; 2006 May; 33(4):170-6. PubMed ID: 16586307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.